These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Norfloxacin: a new oral chemotherapeutic agent effective against multi-drug-resistant Gram-negative bacteria and cocci. Rational directions for treatment]. Panichi G; Magnanelli S; Giuliano M; Manzo M; Vetere A; Testore GP G Ital Chemioter; 1984; 31(1-2):65-71. PubMed ID: 6236125 [No Abstract] [Full Text] [Related]
7. Norfloxacin for the treatment of uncomplicated urinary tract infections. Bailey RR; Peddie BA; Blake E N Z Med J; 1983 Jun; 96(733):446. PubMed ID: 6222277 [No Abstract] [Full Text] [Related]
8. [Antibacterial activity of norfloxacin and pipemidic acid in a randomized double-blind study]. Zerqueni G; Rocca Rossetti S Minerva Urol Nefrol; 1984; 36(3):247-51. PubMed ID: 6241966 [No Abstract] [Full Text] [Related]
10. Treatment of acute urinary infection by norfloxacin or nalidixic acid/citrate: a multi-centre comparative study. Reeves DS; Lacey RW; Mummery RV; Mahendra M; Bint AJ; Newsom SW J Antimicrob Chemother; 1984 May; 13 Suppl B():99-105. PubMed ID: 6234282 [TBL] [Abstract][Full Text] [Related]
11. [Nalidixic acid in chronic urinary tract infections]. Gasser G; Neuhold R Wien Med Wochenschr; 1967 Mar; 117(8):192-6. PubMed ID: 5589339 [No Abstract] [Full Text] [Related]
12. [Norfloxacin treatment of acute cystitis in the female and bacterial prostatitis]. Bischoff W Fortschr Med; 1985 Feb; 103(8):225-8. PubMed ID: 3156797 [No Abstract] [Full Text] [Related]
13. [Therapy results with nalidixic acid in chronic urinary tract infection]. Broghammer H Arzneimittelforschung; 1968 Sep; 18(9):1139-43. PubMed ID: 4885373 [No Abstract] [Full Text] [Related]
14. [Comparative evaluation of norfloxacin and cinoxacin in the therapy of complicated infections of the urinary tract]. Cristiano P; Morelli G; Simioli F; Iovene MR; Della Vittoria Scarpati M; Manguso L Minerva Med; 1989 Apr; 80(4):393-5. PubMed ID: 2657499 [TBL] [Abstract][Full Text] [Related]
15. Urinary tract infections--causative organisms and their varying sensitivity over a five year period. Salgia P; Mani MK; Mukerji S; Sawant M J Assoc Physicians India; 1984 Dec; 32(12):1033-7. PubMed ID: 6526794 [No Abstract] [Full Text] [Related]
16. Treatment of simple urinary tract infections in general practice with a 3-day course of norfloxacin. Kirby CP J Antimicrob Chemother; 1984 May; 13 Suppl B():107-12. PubMed ID: 6234270 [TBL] [Abstract][Full Text] [Related]
17. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates. Piccolomini R; Allocati N; Catamo G Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505 [TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activity of norfloxacin and four other chemotherapeutics against urinary gram-negative isolates. Esposito S; Galante D; Pennucci C; Barba D; Limauro D; Scioli C Chemioterapia; 1984 Jun; 3(3):196-9. PubMed ID: 6241506 [TBL] [Abstract][Full Text] [Related]
19. Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients. Leigh DA; Smith EC; Marriner J J Antimicrob Chemother; 1984 May; 13 Suppl B():79-83. PubMed ID: 6234279 [TBL] [Abstract][Full Text] [Related]
20. Norfloxacin: in vitro activity compared with that of seven other antibacterial agents against urinary tract pathogens. Digranes A; Dibb WL; Ostervold B Acta Pathol Microbiol Immunol Scand B; 1984 Apr; 92(2):101-6. PubMed ID: 6233841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]